These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 19480415

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Automated synthesis, characterization and biological evaluation of [(68)Ga]Ga-AMBA, and the synthesis and characterization of (nat)Ga-AMBA and [(67)Ga]Ga-AMBA.
    Cagnolini A, Chen J, Ramos K, Skedzielewski TM, Lantry LE, Nunn AD, Swenson RE, Linder KE.
    Appl Radiat Isot; 2010 Dec; 68(12):2285-92. PubMed ID: 20638858
    [Abstract] [Full Text] [Related]

  • 4. 177Lu-AMBA biodistribution, radiotherapeutic efficacy, imaging, and autoradiography in prostate cancer models with low GRP-R expression.
    Maddalena ME, Fox J, Chen J, Feng W, Cagnolini A, Linder KE, Tweedle MF, Nunn AD, Lantry LE.
    J Nucl Med; 2009 Dec; 50(12):2017-24. PubMed ID: 19910427
    [Abstract] [Full Text] [Related]

  • 5. Isolation of a 177Hf complex formed by beta-decay of a 177Lu-labeled radiotherapeutic compound and NMR structural elucidation of the ligand and its Lu and Hf complexes.
    Cagnolini A, D'Amelio N, Metcalfe E, Nguyen HD, Aime S, Swenson RE, Linder KE.
    Inorg Chem; 2009 Apr 06; 48(7):3114-24. PubMed ID: 19243162
    [Abstract] [Full Text] [Related]

  • 6. Synthesis, stabilization and formulation of [177Lu]Lu-AMBA, a systemic radiotherapeutic agent for Gastrin Releasing Peptide receptor positive tumors.
    Chen J, Linder KE, Cagnolini A, Metcalfe E, Raju N, Tweedle MF, Swenson RE.
    Appl Radiat Isot; 2008 Apr 06; 66(4):497-505. PubMed ID: 18178448
    [Abstract] [Full Text] [Related]

  • 7. Species differences of bombesin analog interactions with GRP-R define the choice of animal models in the development of GRP-R-targeting drugs.
    Maina T, Nock BA, Zhang H, Nikolopoulou A, Waser B, Reubi JC, Maecke HR.
    J Nucl Med; 2005 May 06; 46(5):823-30. PubMed ID: 15872357
    [Abstract] [Full Text] [Related]

  • 8. Selective in vitro targeting of GRP and NMB receptors in human tumours with the new bombesin tracer 177Lu-AMBA.
    Waser B, Eltschinger V, Linder K, Nunn A, Reubi JC.
    Eur J Nucl Med Mol Imaging; 2007 Jan 06; 34(1):95-100. PubMed ID: 16909223
    [Abstract] [Full Text] [Related]

  • 9. Alpha- versus beta-particle radiopeptide therapy in a human prostate cancer model (213Bi-DOTA-PESIN and 213Bi-AMBA versus 177Lu-DOTA-PESIN).
    Wild D, Frischknecht M, Zhang H, Morgenstern A, Bruchertseifer F, Boisclair J, Provencher-Bolliger A, Reubi JC, Maecke HR.
    Cancer Res; 2011 Feb 01; 71(3):1009-18. PubMed ID: 21245097
    [Abstract] [Full Text] [Related]

  • 10. Multimodality imaging and preclinical evaluation of 177Lu-AMBA for human prostate tumours in a murine model.
    Liu IH, Chang CH, Ho CL, Chiu SP, Lee WC, Chang TJ, Chen LC, Wu YH, Chuang CH, Fu YK, Lee TW.
    Anticancer Res; 2010 Oct 01; 30(10):4039-48. PubMed ID: 21036718
    [Abstract] [Full Text] [Related]

  • 11. Radiochemical investigations of [188Re(H2O)(CO)3-diaminopropionic acid-SSS-bombesin(7-14)NH2]: syntheses, radiolabeling and in vitro/in vivo GRP receptor targeting studies.
    Smith CJ, Sieckman GL, Owen NK, Hayes DL, Mazuru DG, Volkert WA, Hoffman TJ.
    Anticancer Res; 2003 Oct 01; 23(1A):63-70. PubMed ID: 12680195
    [Abstract] [Full Text] [Related]

  • 12. In vitro binding evaluation of 177Lu-AMBA, a novel 177Lu-labeled GRP-R agonist for systemic radiotherapy in human tissues.
    Thomas R, Chen J, Roudier MM, Vessella RL, Lantry LE, Nunn AD.
    Clin Exp Metastasis; 2009 Oct 01; 26(2):105-19. PubMed ID: 18975117
    [Abstract] [Full Text] [Related]

  • 13. In vitro and in vivo application of radiolabeled gastrin-releasing peptide receptor ligands in breast cancer.
    Dalm SU, Martens JW, Sieuwerts AM, van Deurzen CH, Koelewijn SJ, de Blois E, Maina T, Nock BA, Brunel L, Fehrentz JA, Martinez J, de Jong M, Melis M.
    J Nucl Med; 2015 May 01; 56(5):752-7. PubMed ID: 25791989
    [Abstract] [Full Text] [Related]

  • 14. Comparative study on DOTA-derivatized bombesin analog labeled with 90Y and 177Lu: in vitro and in vivo evaluation.
    Koumarianou E, Mikołajczak R, Pawlak D, Zikos X, Bouziotis P, Garnuszek P, Karczmarczyk U, Maurin M, Archimandritis SC.
    Nucl Med Biol; 2009 Aug 01; 36(6):591-603. PubMed ID: 19647165
    [Abstract] [Full Text] [Related]

  • 15. Design, preparation, in vitro and in vivo evaluation of (99m)Tc-N2S2-Tat(49-57)-bombesin: a target-specific hybrid radiopharmaceutical.
    Santos-Cuevas CL, Ferro-Flores G, Arteaga de Murphy C, Ramírez Fde M, Luna-Gutiérrez MA, Pedraza-López M, García-Becerra R, Ordaz-Rosado D.
    Int J Pharm; 2009 Jun 22; 375(1-2):75-83. PubMed ID: 19393305
    [Abstract] [Full Text] [Related]

  • 16. Structural assessment and biological evaluation of two N3S bombesin derivatives.
    Gourni E, Bouziotis P, Benaki D, Loudos G, Xanthopoulos S, Paravatou-Petsotas M, Mavri-Vavagianni M, Pelecanou M, Archimandritis SC, Varvarigou AD.
    J Med Chem; 2009 Jul 23; 52(14):4234-46. PubMed ID: 19522464
    [Abstract] [Full Text] [Related]

  • 17. In vitro and in vivo characterization of 177Lu-huA33: a radioimmunoconjugate against colorectal cancer.
    Almqvist Y, Steffen AC, Tolmachev V, Divgi CR, Sundin A.
    Nucl Med Biol; 2006 Nov 23; 33(8):991-8. PubMed ID: 17127172
    [Abstract] [Full Text] [Related]

  • 18. Molecular imaging, pharmacokinetics, and dosimetry of In-AMBA in human prostate tumor-bearing mice.
    Ho CL, Liu IH, Wu YH, Chen LC, Chen CL, Lee WC, Chuang CH, Lee TW, Lin WJ, Shen LH, Chang CH.
    J Biomed Biotechnol; 2011 Nov 23; 2011():101497. PubMed ID: 21660132
    [Abstract] [Full Text] [Related]

  • 19.
    Zhang H.
    ; 2004 Nov 23. PubMed ID: 20641607
    [Abstract] [Full Text] [Related]

  • 20. In Vitro Mouse and Human Serum Stability of a Heterobivalent Dual-Target Probe That Has Strong Affinity to Gastrin-Releasing Peptide and Neuropeptide Y1 Receptors on Tumor Cells.
    Ghosh A, Raju N, Tweedle M, Kumar K.
    Cancer Biother Radiopharm; 2017 Feb 23; 32(1):24-32. PubMed ID: 28186846
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.